VALENCIA, Calif., andMELBOURNE, Australia, October 20, 2022 - AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), AVITA Medical,Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading thedevelopment and commercialization of first-in-class devices and autologouscellular therapies for skin restoration, announced today that it will reportits third quarter 2022 financial results after the close of the U.S. financialmarkets on Thursday, November 10, 2022. AVITA Medical will host a conferencecall and webcast that day at 1:30 p.m. Pacific Time (Friday, November 11, 2022,at 8:30 a.m. Australian Eastern Daylight Time) to discuss its financial resultsand recent highlights.
To access the live call via telephone, please register in advance using thelink here.Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique personal PIN that can be used to join the call.
The live webcast of the call may be accessed by visiting the Events section of the AVITA Medical’s website at ir.avitamedical.com. A replay of the webcast will be available shortly after the conclusion of the call.
FDA Breakthrough Device Designations for VITILIGO & Soft Tissue for the RECELL® System, page-33
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.03 |
Change
-0.050(1.62%) |
Mkt cap ! $213.3M | |||
| Open | High | Low | Value | Volume |
| $3.08 | $3.08 | $3.00 | $295.3K | 97.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1819 | $3.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.05 | 71 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |